Anuh Pharma Limited (NSE:ANUHPHR)

Market Cap	7.78B -26.2%
Revenue (ttm)	7.72B +16.7%
Net Income	410.46M -13.3%
EPS	4.10 -13.2%
Shares Out	n/a
PE Ratio	18.96
Forward PE	n/a
Dividend	1.50 (1.88%)
Ex-Dividend Date	Aug 5, 2026

Volume	60,966
Open	78.92
Previous Close	78.90
Day's Range	76.50 - 79.60
52-Week Range	67.00 - 114.84
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 295
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ANUHPHR

Financial Performance

In fiscal year 2026, Anuh Pharma's revenue was 7.72 billion, an increase of 16.65% compared to the previous year's 6.62 billion. Earnings were 410.46 million, a decrease of -13.32%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error